Akero Therapeutics (AKRO) Q4 2025 Earnings

Nov 7Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.16
-1.06
-0.96
-0.86

Details

Expected EPS
-0.954043
Actual EPS
-0.945
Surprise EPS
0.01
Surprise Percent
+0.95%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-0.945⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts